Journal of Hepatocellular Carcinoma

J Hepatocell Carcinoma

2253-5969

Therapeutic Area

Cytology/Cell Biology, Endocrinology/Metabolism, Epidemiology, Gastroenterology, Hepatology, Metabolomics, Molecular Biology, Molecular Medicine, Oncology, Radiology, Research, Surgery

Cytologists/Cell Biologists, Gastroenterologists, Hepatologists, Molecular Biologists, Oncologists, Radiation Oncologists, Radiologists, Researchers, Scientists, Scientists - Research/Biomedical Aging, Surgical Oncologists

The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal. The journal provides the international community with a platform for the dissemination and study of clinical, translational, and basic research findings in this rapidly developing field. Primary liver tumors, primarily hepatocellular carcinoma (HCC), are the third leading cause of cancer death worldwide, with around 750,000 new cases annually, and around 700,000 deaths. While 80% occurs in the developing world, the incidence is beginning to decline due to hepatitis B vaccination and developments in food hygiene; conversely, there is an increasing incidence in the developed world, partly due to metabolic syndrome, obesity and diabetes. The journal welcomes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of HCC, spanning from basic laboratory research through to clinical and translational research. Specific topics covered by the journal include: Cell signaling pathways; Molecular tumor classification and prognostication; New drugs and other therapies; New radiology approaches; Epidemiology, surveillance, and prevention and psychosocial aspects and quality of life issues.

No associations affiliated with this journal

Dove Medical Press Ltd.

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Author Submission Guidelines